vision changes with tirzepatide GLP-1 Medications and Your Vision: What You Should Know Zepbound and Vision Loss: 20

Yes, Zepbound has been approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia

Rare side effects include difficulty swallowing, hives, and chest tightness, though these are uncommon enough that large-scale safety data has not linked sermorelin to clinically significant adverse events

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human bloodbrain barrier

PMCID: PMC3181657

Gross et al 61 showed that anti-VEGF treatment is noninferior to photocoagulation in patients with and without DME, and Sivaprasad et al 62 showed that anti-VEGF treatment is superior in patients without DME